EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Dinuclear Rhenium(I) Tricarbonyl Complexes as Anticancer Drug Candidates

Nicolás Montesdeoca, Reema L Borkar, Malaichamy Sathiyendiran, Johannes Karges iD

Chemistry – A European Journal · 06.06.2024 · 30 (32)

DOI: 10.1002/chem.202400217 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry – A European Journal, online erschienen am 03.05.2024. Verfasst von Nicolás Montesdeoca und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Chemistry and Biochemistry, Ruhr-University Bochum, Universitätsstrasse 150, 44780, Bochum, Germany. Hauptthemen laut MEDLINE: Rhenium, Antineoplastic Agents, Coordination Complexes, Apoptosis. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fonds der Chemischen Industrie, Aventis Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer is one of the deadliest diseases worldwide. Chemotherapy remains one of the most dominant forms for anticancer treatment. Despite their clinical success, the used chemotherapeutic agents are associated with severe side effect and pharmacological limitations. To overcome these drawbacks there is a need for the development of new types of chemotherapeutic agents. Herein, the chemical synthesis and biological evaluation of dinuclear rhenium(I) complexes as potential chemotherapeutic drug candidates are proposed. The metal complexes were found to be internalized by an energy dependent endocytosis pathway, primary accumulating in the mitochondria. The rhenium(I) complexes demonstrated to induce cell death against a variety of cancer cells in the micromolar range through apoptosis. The lead compound showed to eradicate a pancreatic carcinoma multicellular tumor spheroid at micromolar concentrations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RheniumAntineoplastic AgentsCoordination ComplexesApoptosisHumansCell Line, TumorMitochondriaDrug Screening Assays, AntitumorCell Proliferation

Stichwörter der Autor:innen

Bioinorganic ChemistryChemotherapyMedicinal Inorganic ChemistryMetals in MedicineRhenium

Substanzen

RheniumAntineoplastic AgentsCoordination Complexes

Autor:innen und Institutionen

  • Faculty of Chemistry and Biochemistry, Ruhr-University Bochum, Universitätsstrasse 150, 44780, Bochum, Germany.
  • School of Chemistry, University of Hyderabad, Hyderabad, 500 046, India.

ORCID-Profile: Johannes Karges

Förderung

  • Fonds der Chemischen Industrie
  • Aventis Foundation

Zitieren

APA

Montesdeoca, N., Borkar, R. L., Sathiyendiran, M., & Karges, J. (2024). Dinuclear Rhenium(I) Tricarbonyl Complexes as Anticancer Drug Candidates. Chemistry – A European Journal, 30(32). https://doi.org/10.1002/chem.202400217

Vancouver

Montesdeoca N, Borkar RL, Sathiyendiran M, Karges J. Dinuclear Rhenium(I) Tricarbonyl Complexes as Anticancer Drug Candidates. Chemistry – A European Journal. 2024;30(32). doi:10.1002/chem.202400217

BibTeX
@article{Montesdeoca2024,
  author = {Montesdeoca, Nicolás and Borkar, Reema L and Sathiyendiran, Malaichamy and Karges, Johannes},
  title = {Dinuclear Rhenium(I) Tricarbonyl Complexes as Anticancer Drug Candidates},
  journal = {Chemistry – A European Journal},
  year = {2024},
  volume = {30},
  number = {32},
  doi = {10.1002/chem.202400217}
}
Kostenlos starten →